MEDIGENE N
MEDIGENE N operates in Diversified Metals & Mining.
MEDIGENE N (MDG1) - Total Liabilities
Latest total liabilities as of June 2024: €9.15 Million EUR
Based on the latest financial reports, MEDIGENE N (MDG1) has total liabilities worth €9.15 Million EUR as of June 2024.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
MEDIGENE N - Total Liabilities Trend (2016–2023)
This chart illustrates how MEDIGENE N's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
MEDIGENE N Competitors by Total Liabilities
The table below lists competitors of MEDIGENE N ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Alternate Health Corp
PINK:AHGIF
|
USA | $30.66 Million |
|
Amcomri Entertainment Inc
PINK:AMNNF
|
USA | $3.27 Million |
|
Vodka Brands Corp
PINK:VDKB
|
USA | $182.66K |
|
Tap Resources Inc
PINK:TAPP
|
USA | $184.14K |
Liability Composition Analysis (2016–2023)
This chart breaks down MEDIGENE N's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.39 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.47 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.32 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how MEDIGENE N's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for MEDIGENE N (2016–2023)
The table below shows the annual total liabilities of MEDIGENE N from 2016 to 2023.
| Year | Total Liabilities | Change |
|---|---|---|
| 2023-12-31 | €10.65 Million | -27.32% |
| 2022-12-31 | €14.65 Million | -0.02% |
| 2021-12-31 | €14.65 Million | -32.15% |
| 2020-12-31 | €21.60 Million | -21.16% |
| 2019-12-31 | €27.39 Million | +23.58% |
| 2018-12-31 | €22.16 Million | -13.99% |
| 2017-12-31 | €25.77 Million | -22.20% |
| 2016-12-31 | €33.12 Million | -- |